Xencor Inc (NASDAQ:XNCR)

48.58
Delayed Data
As of 3:59pm ET
 +0.23 / +0.48%
Today’s Change
19.35
Today|||52-Week Range
58.35
+11.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.0B

Company Description

Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Contact Information

Xencor, Inc.
111 West Lemon Avenue
Monrovia California 91016
P:(626) 305-5900
Investor Relations:
(626) 737-8118

Employees

Shareholders

Mutual fund holders73.05%
Other institutional31.45%
Individual stakeholders28.72%

Top Executives

Bassil I. DahiyatPresident, Chief Executive Officer & Director
John J. KuchChief Financial Officer & Senior Vice President
John R. DesjarlaisChief Scientific Officer & Senior VP-Research
Allen YangChief Medical Officer & Senior Vice President
Celia EckertSecretary, General Counsel & Vice President